Skip to content

SmallCap Round Up: Quantum Blockchain, Lunglife AI, Redx Pharma

*

London’s AIM Index continues to work its way lower, having broken through fresh year to date lows ahead of the weekend break and sitting down just over two points at 729.82 by Monday’s close.

  • Quantum Blockchain +15%
  • Lunglife AI +14%
  • Redx Pharma +13%
  • Fulcrum Utilities -61%
  • Light Science Technologies -20%

Quantum Blockchain LON:QBT topped the board, up some 15% by the bell. Profit taking at the end of last week off the back of falling crypto prices has set the stock up well for bargain hunters, even if there has been no step change in the performance of underlying digital assets. The 10% closing spread also needs to be considered here.

Lunglife AI LON:LLAI was in second place, up some 14%. Again there’s no news but this extends the run of gains which initiated off the back of interim results two weeks ago. The stock IPO’d two years ago around the 175p mark before slipping to just 20p in July. Sentiment has truly reversed but the risk now is long term investors being keen to offload the stock after a rollercoaster ride.

RedX Pharma LON:REDX gets the notable mention, up 13% on the day. An FDA drug designation was announced this morning and the news appears to be sufficient to underline support.


Fulcrum Utilities LON:FCRM slipped 61% having announced disappointing full year results this morning along with an intention to delist.

Light Science Technologies LON:LST was down 20% at the close. On Thursday morning the company advised that an asset manager had trimmed its stake, resulting in the stock reversing from four month highs and this looks to be an extension of that news. The company did advise back in June that it expected to meet full year expectations thanks to cost saving measures.

Share this article

Invest with these platforms

Hargreaves Lansdown

IG

Interactive Brokers

Interactive Investor

Charles Stanley

IG

Interactive Brokers

Charles Stanley

Looking for great investing ideas? Get our free newsletter.
Join our UK news channel on WhatsApp

This article does not constitute investment advice.  Do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth company reports

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
CME Group
FP Markets
Pepperstone
Admiral Markets

TMX
WisdomTree
ARK
FxPro
CMC Markets
Back To Top